A Proteomics-Based Approach Identifies the NEDD4 Adaptor NDFIP2 as an Important Regulator of Ifitm3 Levels

Federico Marziali1, Yuxin Song1, Xuan-Nhi Nguyen1

  • 1Centre International de Recherche en Infectiologie (CIRI), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, 69100 Lyon, France.

Viruses
|October 28, 2023
PubMed

Insights

Interferon-induced transmembrane proteins (IFITMs) possess broad antiviral properties. This study identifies NDFIP2 as a key regulator of IFITM3 levels, impacting viral defense mechanisms.

Area of Science:

  • Virology
  • Cell Biology
  • Proteomics

Background:

  • Interferon-induced transmembrane proteins (IFITMs) are crucial for broad-spectrum antiviral defense by inhibiting viral and cellular membrane fusion.
  • IFITM antiviral efficacy depends on protein levels, cellular localization, and post-translational modifications, influenced by various cellular partners.

Purpose of the Study:

  • To identify novel protein partners regulating Interferon-induced transmembrane protein 3 (IFITM3) biology.
  • To elucidate the role of the NDFIP2 protein adaptor in modulating IFITM3 levels and function.

Main Methods:

  • Proteomics-based approach using extracellular vesicles to identify IFITM3 interacting proteins.
  • Mass spectrometry (MS) analysis of vesicle proteomes.
  • Genetic manipulation (inactivation and overexpression) of NDFIP2.

Main Results:

  • NDFIP2 was identified as a key regulator of IFITM3 levels.
  • NDFIP2 acts as a recruitment factor for IFITM3 and NEDD4, mediating their lysosomal distribution.
  • NDFIP2 modulates IFITM3 accumulation, suggesting competition for NEDD4 binding.

Conclusions:

  • NDFIP2 represents a novel regulatory layer for IFITM3, influencing its stability and antiviral activity.
  • The interaction between NDFIP2, IFITM3, and NEDD4 provides new insights into the dynamic control of antiviral responses.